| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2024 |
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study
10.1136/bmjopen-2023-072361
Authors: A. Czira, V. Banks, G. Requena, R. Wood, T. Tritton, R. Wild, C. Compton, A. Ismaila |
| 2024 |
Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case-Control Study
10.2147/clep.s439219
Authors: L. Grønbæk, H. Omeife, L. Ban, C. Crooks, T. Card, P. Jepsen, J. West |
| 2024 |
Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study
10.1093/rheumatology/keae160
Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, J. Van-Tam, A. Abhishek |
| 2024 |
Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study
10.1016/j.canep.2024.102552
Authors: C. Cardwell, R. McDowell, C. Hughes, J. Busby, P. Murchie |
| 2024 |
Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort
10.1186/s12874-024-02175-9
Authors: H. Harrison, S. Ip, C. Renzi, Y. Li, M. Barclay, J. Usher-Smith, G. Lyratzopoulos, A. Wood, A. Antoniou |
| 2024 |
Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK
10.1186/s12916-024-03283-5
Authors: L. Down, M. Barlow, S. Bailey, L. Mounce, S. Merriel, J. Watson, T. Martins |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
10.1111/bcp.16039
Authors: S. Shapiro, H. Yin, O. H. Y. Yu, L. Azoulay |
| 2024 |
How common are side effects of treatment to prevent gout flares when starting allopurinol?
10.1136/bmj.q514
Authors: H. Saul, B. Deeney, L. Swaithes, E. Roddy |
| 2024 |
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study
10.1016/j.ijid.2024.01.002
Authors: S. Ghosh, A. Antunes, H. Rinta-Kokko, E. Chaparova, S. Lay-Flurrie, A. Tricotel, F. Andersson |
| 2024 |
Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data
10.1186/s12931-024-02672-x
Authors: H. Whittaker, A. Torkpour, J. Quint |
| 2024 |
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
10.1093/bjd/ljae133
Authors: V. Eleftheriadou, C. Delattre, S. Chetty-Mhlanga, C. Lee, L. Girardat-Rotar, I. Khan, A. Mathew, A. Thompson |
| 2024 |
5-year mental health outcomes for children and adolescents presenting with psychiatric symptoms to general practitioners in England: a retrospective cohort study
10.1016/s2215-0366(24)00038-5
Authors: M. Senior, M. Pierce, V. Taxiarchi, S. Garg, D. Edge, T. Newlove-Delgado, S. Neufeld, K. Abel |
| 2024 |
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
10.1136/rmdopen-2023-003980
Authors: A. Abhishek, M. Grainge, T. Card, H. Williams, M. Taal, G. Aithal, C. Fox, C. Mallen, M. Stevenson, G. Nakafero, R. Riley |
| 2024 |
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
10.1136/bmj-2023-078242
Authors: N. Simms-Williams, N. Treves, H. Yin, S. Lu, O. Yu, R. Pradhan, C. Renoux, S. Suissa, L. Azoulay |
| 2024 |
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study
10.1097/inf.0000000000004213
Authors: J. Yang, K. Andersen, K. Rai, T. Tritton, T. Mugwagwa, C. Tsang, M. Reimbaeva, L. McGrath, P. Payne, B. Backhouse, D. Mendes, R. Butfield, R. Wood, J. Nguyen |
| 2024 |
The long-term impact of vaginal surgical mesh devices on pain clinic and psychological service referrals, anti-inflammatory testing and pelvic scans in UK primary care: A cohort study with the Clinical Practice Research Datalink
10.1111/1471-0528.17828
Authors: E. McFadden, C. Heneghan |
| 2024 |
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study
10.1136/thorax-2023-220887
Authors: R. Gupta, A. Morgan, P. George, J. Quint |
| 2024 |
Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records
10.1016/s2666-7568(23)00285-4
Authors: E. Buzasi, H. Carreira, G. Funston, K. Mansfield, H. Forbes, H. Strongman, K. Bhaskaran |
| 2024 |
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study
10.1136/bmjopen-2023-078135
Authors: R. Hopkins, K. Young, N. Thomas, J. Godwin, D. Raja, B. Mateen, R. Challen, S. Vollmer, B. Shields, A. McGovern, J. Dennis |
| 2024 |
A Harmonised Approach to Curating Research-Ready Datasets for Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD) in England, Wales and Scotland Using CPRD, SAIL Databank and DataLoch
10.2147/clep.s437937
Authors: S. Hatam, S. Scully, S. Cook, H. Evans, A. Hume, C. Kallis, I. Farr, C. Orton, A. Sheikh, J. Quint |
| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2023 |
Evaluating Ethnic Variations in the Risk of Infections in People With Prediabetes and Type 2 Diabetes: A Matched Cohort Study
10.2337/dc22-2394
Authors: I. Carey, J. Critchley, U. Chaudhry, S. DeWilde, E. Limb, D. Cook, P. Whincup, T. Harris |
| 2023 |
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD
10.1002/pds.5637
Authors: J. Gulikers, A. van Veelen, J. Driessen, P. Souverein, V. Tjan-Heijnen, L. Hendriks, Rmjm van Geel, S. Croes |
| 2023 |
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
10.1016/s0140-6736(23)00457-9
Authors: N. Conrad, S. Misra, J . Y. Verbakel, G. Verbeke, G. Molenberghs, P. Taylor, J. Mason, N. Sattar, J. McMurray, I. McInnes, K. Khunti, G. Cambridge |
| 2023 |
Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2
10.1093/eurjpc/zwad187
Authors: S. Hageman, C. Petitjean, L. Pennells, S. Kaptoge, R. Pajouheshnia, T. Tillmann, M. Blaha, R. McClelland, K. Matsushita, V. Nambi, O. Klungel, P. Souverein, Y. van der Schouw, W. Verschuren, N. Lehmann, R. Erbel, K. Jöckel, E. Di Angelantonio, F. Visseren, J. Dorresteijn |
| 2023 |
Real-world comparative effectiveness of three single-inhaler dual bronchodilators for the treatment of chronic obstructive pulmonary disease
10.1183/13993003.00538-2023
Authors: J. Li, S. Dell'Aniello, P. Ernst, S. Suissa |
| 2023 |
Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England
10.1136/thorax-2022-219320
Authors: H. Whittaker, K. Rothnie, J. Quint |
| 2023 |
Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study
10.1111/dom.15106
Authors: S. Larose, C. Filliter, R. Platt, O. H. Y. Yu, K. Filion |
| 2023 |
Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques
10.1002/sim.9771
Authors: A. Pate, M. Sperrin, R. Riley, J. Sergeant, T. Van Staa, N. Peek, M. Mamas, G. Lip, M. O'Flaherty, I. Buchan, G. Martin |
| 2023 |
SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study
10.1111/bcp.15787
Authors: S. Aloe, C. Filliter, S. Salmasi, S. Igweokpala, O. H. Y. Yu, V. Tagalakis, K. Filion |
| 2023 |
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK
10.1001/jamadermatol.2023.1400
Authors: T. Chen, I. Iskandar, R. Parisi, M. Pierce, C. Tower, C. Kleyn, C. Griffiths, D. Ashcroft |
| 2023 |
Independent Associations of Incident Epilepsy and Enzyme-Inducing and Non-Enzyme-Inducing Antiseizure Medications With the Development of Osteoporosis
10.1001/jamaneurol.2023.1580
Authors: C. Josephson, A. Gonzalez-Izquierdo, S. Denaxas, T. Sajobi, K. Klein, S. Wiebe |
| 2023 |
Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes
10.1038/s41416-023-02249-3
Authors: R. Kerrison, A. Jones, J. Peng, G. Price, J. Verne, E. Barley, C. Lugton |
| 2023 |
Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study
10.1016/j.numecd.2023.04.003
Authors: Y. Chudasama, K. Khunti, B. Coles, C. Gillies, N. Islam, A. Rowlands, S. Seidu, C. Razieh, M. Davies, N. Samani, T. Yates, F. Zaccardi |
| 2023 |
Consultation Rate and Mode by Deprivation in English General Practice From 2018 to 2022: Population-Based Study
10.2196/44944
Authors: E. Vestesson, K. De Corte, E. Crellin, J. Ledger, M. Bakhai, G. Clarke |
| 2023 |
Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in England
10.1111/coa.14070
Authors: V. Benson, Q. Fu, S. Yang, A. Sousa, R. Chan, P. Howarth, C. Hopkins |
| 2023 |
An algorithm-based approach to ascertain patients with rare diseases in electronic health records using hypereosinophilic syndrome as an example
10.1002/pds.5655
Authors: G. Requena, S. Joksaite, N. Galwey, R. Jakes |
| 2023 |
The impact of the COVID-19 pandemic on referrals to musculoskeletal services from primary care and subsequent incidence of inflammatory rheumatic musculoskeletal disease: an observational study
10.1093/rap/rkad044
Authors: C. Burton, R. Bajpai, K. Mason, J. Bailey, K. Jordan, C. Mallen, V. Welsh |
| 2023 |
Preconception management of hyperthyroidism and thyroid status in subsequent pregnancy: a population-based cohort study
10.1210/clinem/dgad276
Authors: C. Minassian, L. Allen, O. Okosieme, B. Vaidya, P. Taylor |
| 2023 |
All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD)
10.2147/copd.s407085
Authors: A. Raslan, J. Quint, S. Cook |
| 2023 |
Body mass index and survival in people with heart failure
10.1136/heartjnl-2023-322459
Authors: N. Jones, J. Ordonez-Mena, A. Roalfe, K. Taylor, C. Goyder, F. Hobbs, C. Taylor |
| 2023 |
Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population-based study
10.1016/s2352-4642(23)00126-8
Authors: A. Trafford, M. Carr, D. Ashcroft, C. Chew-Graham, E. Cockcroft, L. Cybulski, E. Garavini, S. Garg, T. Kabir, N. Kapur, R. Temple, R. Webb, P. Mok |
| 2023 |
Identifying subtypes of heart failure from three electronic health record sources with machine learning: an external, prognostic, and genetic validation study
10.1016/s2589-7500(23)00065-1
Authors: A. Banerjee, A. Dashtban, S. Chen, L. Pasea, J. Thygesen, G. Fatemifar, B. Tyl, T. Dyszynski, F. Asselbergs, L. Lund, T. Lumbers, S. Denaxas, H. Hemingway |
| 2023 |
Trends in musculoskeletal consultations and prescribing: an electronic primary care records study
10.3399/bjgp.2022.0648
Authors: Victoria Welsh, Kayleigh Mason, James Bailey, Ram Bajpai, Kelvin Jordan, Christian Mallen, Claire Burton |
| 2023 |
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK
10.1136/bmj-2022-074678
Authors: G. Nakafero, M. Grainge, H. Williams, T. Card, M. Taal, G. Aithal, C. Fox, C. Mallen, D. van der Windt, M. Stevenson, R. Riley, A. Abhishek |
| 2023 |
Evaluating the Performance of High-Dimensional Propensity Scores Compared with Standard Propensity Scores for Comparing Antihypertensive Therapies in the CPRD GOLD Database
10.1007/s40119-023-00316-7
Authors: V. Simon, J. Vadel |
| 2023 |
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study
10.1136/bmjopen-2022-070985
Authors: E. Eworuke, M. Shinde, L. Hou, M. Paterson, P. Jensen, J. Maro, A. Rai, D. Scarnecchia, D. Pennap, D. Woronow, R. Ghosh, S. Welburn, A. Pottegard, R. Platt, H. Lee, M. Bradley |
| 2023 |
Mortality in children with epilepsy: Cohort study using the clinical practice research datalink
10.1016/j.seizure.2023.05.020
Authors: C. Schnier, R. Chin |
| 2023 |
The prevalent new-user design for studies with no active comparator: The example of statins and cancer
10.1097/ede.0000000000001628
Authors: S. Suissa, S. Dell'Aniello, C. Renoux |
